What's new — by condition¶
Generated 2026-11-01 from the publication dates of every cited paper across all conditions.
Where the evidence is moving, and what specifically has moved. Conditions are ordered by how many of their cited papers appeared in the last three months — the top is the current frontier, the bottom is settled ground.
At a glance¶
| Condition | Newest cited paper | Last 3 months | Last year | Total cited |
|---|---|---|---|---|
| Lung adenocarcinoma | 2026-10-05 | 36 | 58 | 321 |
| Bipolar disorder | 2026-11-01 | 32 | 55 | 423 |
| Hypertension | 2026-11-01 | 31 | 79 | 803 |
| Hypertensive heart disease | 2026-10-09 | 31 | 41 | 274 |
| ADHD | 2026-10-09 | 26 | 66 | 481 |
| Ischemic heart disease | 2026-10-26 | 23 | 30 | 277 |
| Stroke | 2026-10-07 | 20 | 31 | 401 |
| Alzheimers disease | 2026-10-09 | 19 | 42 | 389 |
| Neuropathic pain | 2026-11-01 | 19 | 24 | 310 |
| Rheumatoid arthritis | 2026-10-06 | 18 | 40 | 282 |
| Type 2 diabetes | 2026-10-17 | 18 | 32 | 265 |
| Ptsd | 2026-10-08 | 18 | 30 | 421 |
| Chronic kidney disease | 2026-10-09 | 17 | 49 | 329 |
| Type 1 diabetes | 2026-10-02 | 17 | 39 | 276 |
| Hepatocellular carcinoma | 2026-11-01 | 17 | 24 | 347 |
| Osteoarthritis | 2026-10-15 | 16 | 59 | 557 |
| Thoracic aortic aneurysm | 2026-10-02 | 16 | 34 | 359 |
| Irritable bowel syndrome | 2026-10-01 | 15 | 47 | 381 |
| Cataracts | 2026-10-02 | 15 | 42 | 465 |
| Colorectal adenocarcinoma | 2026-10-02 | 15 | 33 | 319 |
| COPD | 2026-10-02 | 15 | 24 | 316 |
| Masld | 2026-11-01 | 13 | 48 | 373 |
| Vascular dementia | 2026-10-09 | 13 | 38 | 431 |
| Generalized anxiety disorder | 2026-10-08 | 11 | 26 | 405 |
| Melanoma | 2026-10-09 | 10 | 67 | 639 |
| Depression | 2026-10-02 | 10 | 43 | 395 |
| Migraine | 2026-10-02 | 10 | 23 | 397 |
| Anorexia nervosa | 2026-10-08 | 9 | 30 | 297 |
| Degenerative disc disease | 2026-10-09 | 9 | 25 | 359 |
| Asthma | 2026-10-04 | 9 | 19 | 414 |
| Spinal stenosis | 2026-10-01 | 5 | 25 | 347 |
| Retinoblastoma | 2026-10-01 | 5 | 19 | 373 |
| Lung squamous cell carcinoma | 2026-10-08 | 5 | 12 | 334 |
| Uterine adenosarcoma | 2026-10-02 | 4 | 6 | 73 |
| Fibromyalgia | 2026-10-05 | 2 | 21 | 395 |
By condition¶
Lung adenocarcinoma¶
last week: 0 · last month: 14 · last 2 months: 34 · last 3 months: 36 · last 6 months: 46 · last year: 58 · 321 cited in total · full recency page
Published in the last 3 months:
| Published | Paper | Cited on |
|---|---|---|
| 2026-10-05 | Combined amivantamab, lazertinib, and bevacizumab in patients with EGFR-mutant advanced non-small-cell lung cancer with acquired resistance to a third-generation EGFR tyrosine-kinase inhibitor (ETOP 18-21 AMAZE-lung): a prospective, international, multicentre, single-arm, phase 2 trial — Lancet Respir Med (PMID 42833236) | clinical-trials-landscape, egfr-disease |
| 2026-10-05 | Type II ROS1 Inhibition Overcomes Type I Inhibitor Resistance in ROS1 Fusion-Positive Lung Cancers: A Phase II Trial of Cabozantinib — Clin Cancer Res (PMID 42832369) | alk-ros1-and-fusion-drivers |
| 2026-10-05 | Smoking Cessation Among Underserved Patients Referred for Lung Cancer Screening: A Randomized Clinical Trial — JAMA (PMID 42832220) | screening-and-early-detection |
| 2026-10-04 | Envonalkib Versus Crizotinib in Treatment-Naive ALK-Positive Non-Small Cell Lung Cancer: Final Efficacy and Biomarker Analyses of the Randomized Phase III Study — MedComm (2020) (PMID 42830869) | alk-ros1-and-fusion-drivers |
| 2026-10-03 | Trial-specific absolute disease-free survival effects of postoperative PD-1/PD-L1 blockade after complete resection of NSCLC: A systematic review — Lung Cancer (PMID 42843316) | early-stage-and-perioperative-therapy |
| 2026-10-02 | Therapy for Stage IV Non-Small Cell Lung Cancer With Driver Alterations: ASCO Living Guideline, Version 2026.3.4 — J Clin Oncol (PMID 42956324) | guidelines |
| 2026-10-02 | Local ablative therapy plus systemic treatment versus systemic therapy alone in oligometastatic non-small cell lung cancer: a systematic review and meta-analysis of randomized trials — Int J Clin Oncol (PMID 42955614) | egfr-disease, systemic-therapy |
| 2026-10-02 | Benmelstobart With or Without Anlotinib After Chemoradiotherapy for Unresectable Non-Small Cell Lung Cancer: The R-ALPS Randomized Clinical Trial — JAMA Oncol (PMID 42955021) | clinical-trials-landscape, early-stage-and-perioperative-therapy |
| 2026-10-02 | KEYNOTE-867: A Phase III, Randomized, Double-Blind Study of Stereotactic Body Radiotherapy With Pembrolizumab for Unresected Stage I or II Non-Small Cell Lung Cancer — J Clin Oncol (PMID 42950173) | clinical-trials-landscape, early-stage-and-perioperative-therapy |
| 2026-10-02 | Izalontamab brengitecan versus platinum-based chemotherapy in EGFR-mutated advanced non-squamous non-small-cell lung cancer after progression on third-generation EGFR tyrosine kinase inhibitors (PANKU-Lung01): a multicentre, randomised, open-label, phase 3 trial in China — Lancet (PMID 42933461) | clinical-trials-landscape, egfr-disease, systemic-therapy |
…and 26 more in the last 3 months — see the full recency page.
Bipolar disorder¶
last week: 5 · last month: 12 · last 2 months: 27 · last 3 months: 32 · last 6 months: 46 · last year: 55 · 423 cited in total · full recency page
Published in the last 3 months:
| Published | Paper | Cited on |
|---|---|---|
| 2026-11-01 | Women With Bipolar Disorder are at Increased Risk of Sarcopenia — Bipolar Disord (PMID 42897866) | suicide-mortality-and-physical-health |
| 2026-11-01 | Bipolar Disorder and Perimenopause: An Update — Bipolar Disord (PMID 42811911) | pregnancy-and-reproductive-health |
| 2026-11-01 | Tirzepatide Initiation in Lithium-Treated Bipolar Disorder: Renal Biomarker Trajectories and Lithium Safety Signals Over 12 Months in a Real-World Cohort — Hum Psychopharmacol (PMID 42803597) | lithium |
| 2026-11-01 | Comparative Effectiveness of Lithium- Vs. Valproate-Based Combinations With Atypical Antipsychotics in Preventing Rehospitalization After a First Manic Episode of Bipolar I Disorder — Bipolar Disord (PMID 42765449) | maintenance-and-relapse-prevention |
| 2026-11-01 | Association Between Lithium Use and Suicide-Related Behaviors in Bipolar Disorder: A Multicenter Study — Bipolar Disord (PMID 42713736) | suicide-mortality-and-physical-health |
| 2026-10-09 | Contraceptive use in women of childbearing age with bipolar disorder — BMC Psychiatry (PMID 42850618) | pregnancy-and-reproductive-health |
| 2026-10-08 | Copeptin and urine concentrating capacity predict kidney function decline in lithium-treated patients — Nephrol Dial Transplant (PMID 42847926) | lithium |
| 2026-10-07 | Using multi-trait polygenic scores to predict lithium responsiveness in patients with bipolar disorder — Br J Psychiatry (PMID 42841250) | lithium |
| 2026-10-06 | Cannabis use and subsequent onset of manic symptoms and bipolar disorder: A systematic review and meta-analysis — J Affect Disord (PMID 42838231) | comorbidity-and-differential-diagnosis |
| 2026-10-05 | EDIT-B consortium: an external pan-European validation of an innovative machine learning-based test for bipolar disorder diagnosis — BMJ Ment Health (PMID 42833865) | biomarkers-and-digital-phenotyping |
…and 22 more in the last 3 months — see the full recency page.
Hypertension¶
last week: 1 · last month: 6 · last 2 months: 27 · last 3 months: 31 · last 6 months: 45 · last year: 79 · 803 cited in total · full recency page
Published in the last 3 months:
| Published | Paper | Cited on |
|---|---|---|
| 2026-11-01 | KDOQI Commentary on the 2025 AHA/ACC Guideline for the Prevention, Detection, Evaluation, and Management of High Blood Pressure in Adults — Am J Kidney Dis (PMID 42907045) | guidelines |
| 2026-10-05 | Optimizing Blood Pressure Care in Patients With Resistant Hypertension: 2026 ACC Expert Consensus Decision Pathway: A Report of the American College of Cardiology Solution Set Oversight Committee — J Am Coll Cardiol (PMID 42831847) | guidelines, resistant-and-refractory-hypertension |
| 2026-10-02 | 2026 THS guidelines for the management of hypertension in older adults: Developed by the task force on the management of hypertension of the Taiwan Hypertension Society (THS) and endorsed by the Taiwan Society of Cardiology (TSOC), Taiwan Association of Gerontology and Geriatrics (TAGG), and Taiwan Society of Family Medicine (TSFM) — J Formos Med Assoc (PMID 42926177) | guidelines |
| 2026-10-02 | Bangladesh HEARTS: Lessons Learned from a National Hypertension Control Program, 2018-2026 — Glob Heart (PMID 42921236) | adherence-and-implementation |
| 2026-10-02 | 2026 International Society of Hypertension Global Hypertension Practice Guidelines — J Hypertens (PMID 42909506) | blood-pressure-targets, definition-measurement-and-diagnosis, guidelines, secondary-hypertension |
| 2026-10-02 | Updated practical guide for validation studies of automated cuff blood pressure monitors according to the Universal Standard by the Association for the Advancement of Medical Instrumentation/European Society of Hypertension/International Organization for Standardization (ISO 81060-2:2018) and Amendments 1:2020 and 2:2024 — J Hypertens (PMID 42853222) | definition-measurement-and-diagnosis |
| 2026-10-01 | A Pilot Randomized Study of NAT2 and YEATS4 Pharmacogenetic Return of Results in Adults with Hypertension and African Ancestry: The GUARDD-US PGx Study — Clin Pharmacol Ther (PMID 42894271) | genetics-and-monogenic-forms |
| 2026-10-01 | Postpartum Blood Pressure After Hypertensive Disorders of Pregnancy and Subsequent Cardiovascular Disease: A Population-Based Cohort Study — BJOG (PMID 42888852) | hypertension-in-pregnancy |
| 2026-10-01 | Planned Antihypertensive Deprescribing in Long-Term Care Residents: A Systematic Review of Randomized Evidence — Drugs Aging (PMID 42888381) | special-populations |
| 2026-10-01 | Optimal exercise modalities and doses for blood pressure management in adults with prehypertension and hypertension: A systematic review and Bayesian network meta-analysis — Maturitas (PMID 42887271) | lifestyle-and-dietary-management |
…and 21 more in the last 3 months — see the full recency page.
Hypertensive heart disease¶
last week: 0 · last month: 5 · last 2 months: 20 · last 3 months: 31 · last 6 months: 33 · last year: 41 · 274 cited in total · full recency page
Published in the last 3 months:
| Published | Paper | Cited on |
|---|---|---|
| 2026-10-09 | 2026 ESC Guidelines for the management of heart failure — Eur Heart J (PMID 42661420) | guidelines, heart-failure-management |
| 2026-10-07 | Intensive vs Standard Blood Pressure Lowering in People With and Without Chronic Kidney Disease: A Systematic Review and Meta-Analysis — JAMA Cardiol (PMID 42842238) | blood-pressure-targets |
| 2026-10-06 | Baxdrostat in Resistant and Uncontrolled Hypertension: A Systematic Review and Meta-Analysis — Cardiovasc Drugs Ther (PMID 42837060) | pharmacologic-prevention-and-regression |
| 2026-10-05 | Systolic Blood Pressure Variability and Outcomes in Atrial Fibrillation: A Nationwide Population Study in Korea — J Korean Med Sci (PMID 42843353) | arrhythmia-and-atrial-remodeling |
| 2026-10-05 | Comparative Efficacy of Treatments for Resistant or Uncontrolled Hypertension: A Network Meta-Analysis of Randomized Trials — JACC Adv (PMID 42832922) | pharmacologic-prevention-and-regression |
| 2026-10-01 | Large-scale plasma proteomic profiling enhances prediction of heart failure among hypertensive individuals: prospective insights from the UK Biobank — J Glob Health (PMID 42895254) | biomarkers-and-imaging-markers |
| 2026-10-01 | Blood pressure targets in adults with hypertension — Cochrane Database Syst Rev (PMID 42861682) | blood-pressure-targets |
| 2026-10-01 | Pulsed field ablation with Renal denervation for persistent Atrial fibrIllation: Rationale and design of the PRAISE-AF randomized trial — Am Heart J (PMID 42860163) | clinical-trials-landscape |
| 2026-10-01 | Renal Sympathetic Denervation Plus Pulmonary Vein Isolation for Atrial Fibrillation in Patients with Hypertension: A Meta-Analysis of Randomised Controlled Trials — J Coll Physicians Surg Pak (PMID 42851099) | clinical-trials-landscape |
| 2026-10-01 | Non-linear associations between blood pressure and clinical outcomes in atrial fibrillation: a systematic review and dose-response meta-analysis — Europace (PMID 42663497) | arrhythmia-and-atrial-remodeling |
…and 21 more in the last 3 months — see the full recency page.
ADHD¶
last week: 0 · last month: 4 · last 2 months: 17 · last 3 months: 26 · last 6 months: 36 · last year: 66 · 481 cited in total · full recency page
Published in the last 3 months:
| Published | Paper | Cited on |
|---|---|---|
| 2026-10-09 | Effect of Digital Technology-Based Interventions on Core Symptoms and Cognitive Function in Children With Attention-Deficit/Hyperactivity Disorder: Systematic Review and Meta-Analysis — J Med Internet Res (PMID 42854193) | psychosocial-and-digital-treatment |
| 2026-10-08 | Sustained increases in ADHD medication use after the COVID-19 pandemic: A nationwide register-based study — Scand J Public Health (PMID 42847285) | epidemiology-and-lifespan-course |
| 2026-10-07 | Attention-Deficit/Hyperactivity Disorder and Late-Life Cognitive Impairment — JAMA Psychiatry (PMID 42842281) | adult-adhd, long-term-outcomes-and-quality-of-life |
| 2026-10-04 | A Phase 3, Multicenter, Randomized, Placebo-Controlled Trial Evaluating the Efficacy, Safety, and Tolerability of Serdexmethylphenidate/d-Methylphenidate Capsules in Chinese Children with Attention-Deficit/Hyperactivity Disorder — CNS Drugs (PMID 42830387) | clinical-trials-landscape |
| 2026-10-01 | Adverse sexual and reproductive health outcomes in female adolescents with ADHD and their associations with ADHD medication: a Swedish register-based study — BMJ Ment Health (PMID 42864120) | girls-women-and-hormonal-context |
| 2026-10-01 | Trends in Parent-Reported Developmental Disabilities: 2019-2024 — Pediatrics (PMID 42767652) | epidemiology-and-lifespan-course |
| 2026-09-09 | Therapist-guided Internet-delivered versus Face-to-face CBT for Adults with ADHD: Differential Long-Term Maintenance and Exploratory Correlational Pathways — J Atten Disord (PMID 42717581) | adult-adhd, psychosocial-and-digital-treatment |
| 2026-09-09 | Changes in Characteristics Associated With ADHD and ASD Diagnoses Over Time — JAMA Psychiatry (PMID 42714883) | epidemiology-and-lifespan-course |
| 2026-09-02 | Major adverse cardiac events and mortality associated with ADHD and its treatment in adults with type 2 diabetes: a multi-national cohort study — BMC Med (PMID 42806384) | pharmacologic-treatment |
| 2026-09-02 | National Trends in Severe ADHD and Treatment Among U.S. Children, 2016-2024 — Acad Pediatr (PMID 42805290) | epidemiology-and-lifespan-course |
…and 16 more in the last 3 months — see the full recency page.
Ischemic heart disease¶
last week: 1 · last month: 5 · last 2 months: 12 · last 3 months: 23 · last 6 months: 24 · last year: 30 · 277 cited in total · full recency page
Published in the last 3 months:
| Published | Paper | Cited on |
|---|---|---|
| 2026-10-26 | Fifth Universal Definition of Myocardial Infarction (2026) — Eur Heart J (PMID 42661425) | acute-coronary-syndromes, guidelines |
| 2026-10-23 | 2026 ESC Guidelines on cardiac rehabilitation — Eur Heart J (PMID 42661418) | cardiac-rehabilitation-and-lifestyle, guidelines |
| 2026-10-05 | The Comorbidity-Driven Interleukin-6-Mediated Systemic Inflammation Hypothesis of Heart Failure With Preserved Ejection Fraction: A Decade of Testing Ends in Disappointment — J Card Fail (PMID 42833572) | inflammation-and-residual-risk |
| 2026-10-02 | Correction to: 2026 ESC Guidelines on cardiac rehabilitation: Developed by the task force on cardiac rehabilitation of the European Society of Cardiology (ESC)Endorsed by the European Society of Physical and Rehabilitation Medicine (ESPRM) and World Organization of Family Doctors (WONCA) — Eur Heart J (PMID 42921976) | cardiac-rehabilitation-and-lifestyle, guidelines |
| 2026-10-02 | Correction: Fifth Universal Definition of Myocardial Infarction (2026): On behalf of the Joint European Society of Cardiology (ESC)/American College of Cardiology (ACC)/American Heart Association (AHA)/World Heart Federation (WHF) Task Force for the Universal Definition of Myocardial InfarctionEndorsed by the European Association for Cardio-Thoracic Surgery (EACTS) and the Society of Thoracic Surgeons (STS)Affirmation of Value by the Society for Cardiovascular Angiography and Interventions (SCAI) — Eur Heart J (PMID 42905436) | acute-coronary-syndromes, guidelines |
| 2026-10-01 | ICare-FASTER (Improving Care by Faster Risk Stratification Through Use of High-Sensitivity Point-of-Care Troponin in Patients Presenting With Possible Acute Coronary Syndrome in the Emergency Department): A Stepped-Wedge Cluster-Randomized Trial — Circulation (PMID 42895015) | biomarkers |
| 2026-10-01 | Pelacarsen and Lp(a)HORIZON: Interpreting the Disconnect Between Lipoprotein(a) Lowering and Cardiovascular Outcomes — Am J Med (PMID 42880684) | biomarkers, clinical-trials-landscape, guidelines, inflammation-and-residual-risk, lipid-lowering |
| 2026-10-01 | Interventions to Promote Utilisation of Cardiac Rehabilitation: 2026 Cochrane Systematic Review and Meta-Analysis — Heart Lung Circ (PMID 42823225) | cardiac-rehabilitation-and-lifestyle |
| 2026-09-08 | Correction to: 2026 ACC/AHA/AACVPR/ABC/ACPM/ADA/AGS/APhA/ASPC/NLA/PCNA Guideline on the Management of Dyslipidemia: A Report of the American College of Cardiology/American Heart Association Joint Committee on Clinical Practice Guidelines — Circulation (PMID 42709919) | guidelines |
| 2026-09-03 | Geographic heterogeneity in outcomes of intravascular ultrasound-guided vs angiography-guided percutaneous coronary intervention: a meta-analysis of randomized trials — Eur Heart J (PMID 42690150) | revascularization-pci-and-cabg |
…and 13 more in the last 3 months — see the full recency page.
Stroke¶
last week: 0 · last month: 5 · last 2 months: 15 · last 3 months: 20 · last 6 months: 26 · last year: 31 · 401 cited in total · full recency page
Published in the last 3 months:
| Published | Paper | Cited on |
|---|---|---|
| 2026-10-07 | Effectiveness of interventions for caregiver burden and quality of life of informal caregivers of stroke survivors: a systematic review and meta-analysis — Front Public Health (PMID 42909033) | patient-experience-and-advocacy |
| 2026-10-07 | Tirofiban vs standard antiplatelet therapy in acute branch atheromatous disease-related stroke: a multicenter, randomized, open-label, blinded-endpoint, parallel-group, phase III clinical trial — Lancet Reg Health West Pac (PMID 42894564) | clinical-trials-landscape |
| 2026-10-02 | Correction to: 2026 Guideline for Adult Stroke Rehabilitation and Recovery: A Guideline From the American Heart Association and American Stroke Association — Stroke (PMID 42932410) | guidelines, rehabilitation-and-recovery |
| 2026-10-02 | Trial of Endovascular Therapy for Mild Stroke with Large-Vessel Occlusion — N Engl J Med (PMID 42929671) | acute-ischemic-stroke, clinical-trials-landscape |
| 2026-10-02 | Mechanical Thrombectomy 24 to 72 Hours after Large-Vessel Ischemic Stroke — N Engl J Med (PMID 42929656) | acute-ischemic-stroke, clinical-trials-landscape |
| 2026-10-01 | Bleeding With Asundexian Versus Placebo in Patients With Noncardioembolic Ischemic Stroke or High-Risk TIA: OCEANIC-STROKE Randomized Trial — Circulation (PMID 42866879) | secondary-prevention |
| 2026-10-01 | Tirofiban for Branch Atheromatous Disease-Related Stroke: The STRATEGY Randomized Clinical Trial — JAMA Neurol (PMID 42671865) | clinical-trials-landscape |
| 2026-09-02 | Treatment of Antithrombotic-Associated Intracranial Hemorrhage in Adults: A Focused Guideline Update from the Neurocritical Care Society and the Society of Critical Care Medicine — Neurocrit Care (PMID 42786382) | intracerebral-hemorrhage |
| 2026-09-02 | Tenecteplase Before Thrombectomy at 4.5 to 24 Hours for Basilar Artery Occlusion: The ATTENTION LATE Randomized Clinical Trial — JAMA (PMID 42776543) | acute-ischemic-stroke |
| 2026-09-01 | Factor XIa Inhibitors for Secondary Prevention After Noncardioembolic Stroke: A Systematic Review and Meta-Analysis — Neurology (PMID 42748394) | secondary-prevention |
…and 10 more in the last 3 months — see the full recency page.
Alzheimers disease¶
last week: 0 · last month: 8 · last 2 months: 19 · last 3 months: 19 · last 6 months: 23 · last year: 42 · 389 cited in total · full recency page
Published in the last 3 months:
| Published | Paper | Cited on |
|---|---|---|
| 2026-10-09 | Centrum Semiovale Perivascular Spaces Predict First Hemorrhagic Lesion in Asymptomatic Amyloid-Positive Individuals — Ann Neurol (PMID 42855813) | vascular-and-metabolic-contributions |
| 2026-10-09 | Organizing healthcare delivery in the era of disease-modifying therapies for Alzheimer's Disease: an Italian RAND/UCLA consensus — Neurol Sci (PMID 42850455) | guidelines |
| 2026-10-02 | A phase III trial of ALZT-OP1 (cromolyn + ibuprofen) in early Alzheimer's disease: Primary results and exploratory analyses by APOE4 genotype — J Alzheimers Dis (PMID 42920249) | clinical-trials-landscape |
| 2026-10-02 | Blood biomarkers for Alzheimer's disease: guidance on appropriate testing from the Association of British Neurologists and Royal College of Psychiatrists — Pract Neurol (PMID 42914559) | guidelines |
| 2026-10-02 | Blood-Based Biomarkers as Predictors of All-Cause Dementia: A 13-Year Follow-Up in the Whitehall II Cohort Study — Neurology (PMID 42913444) | fluid-biomarkers |
| 2026-10-02 | Diagnostic reclassification under the AA-2024 biological framework: A real-world comparison with ATN 2018 using cerebrospinal fluid biomarkers — J Alzheimers Dis (PMID 42911077) | diagnostic-criteria-and-biological-definition |
| 2026-10-02 | Real-world safety and efficacy of lecanemab in the treatment of Alzheimer's disease: a systematic review and meta-analysis — J Neurol (PMID 42907679) | anti-amyloid-immunotherapy |
| 2026-10-02 | Cognitive outcomes of low-dose whole-brain radiation therapy in mild Alzheimer's disease: A multicenter, randomized, sham-controlled phase II clinical trial — Radiother Oncol (PMID 42906637) | clinical-trials-landscape |
| 2026-10-01 | Baseline MRI markers and clinical outcomes during anti-amyloid β therapy: A real-world study in a Japanese dementia center — J Prev Alzheimers Dis (PMID 42892274) | anti-amyloid-immunotherapy |
| 2026-10-01 | GLP-1 receptor agonists in Alzheimer's disease and MCI: a meta-analysis — Alzheimers Dement (N Y) (PMID 42890838) | clinical-trials-landscape, vascular-and-metabolic-contributions |
…and 9 more in the last 3 months — see the full recency page.
Neuropathic pain¶
last week: 2 · last month: 4 · last 2 months: 17 · last 3 months: 19 · last 6 months: 22 · last year: 24 · 310 cited in total · full recency page
Published in the last 3 months:
| Published | Paper | Cited on |
|---|---|---|
| 2026-11-01 | Evidence on Glutathione and Boosters for Prevention of Chemotherapy-Induced Neuropathy: A Systematic Review and Network Meta-Analysis — Basic Clin Pharmacol Toxicol (PMID 42876024) | chemotherapy-and-toxic-neuropathy |
| 2026-11-01 | Evaluating Improvement in Pain and Sensory Function When Using High-Frequency (10-kHz) Spinal Cord Stimulation in Individuals With Painful Diabetic Neuropathy: A Multicenter Randomized Controlled Trial (PDN-Sensory) — Diabetes Care (PMID 42713876) | clinical-trials-landscape, diabetic-neuropathic-pain, neuromodulation |
| 2026-10-06 | Efficacy of Cryotherapy in Preventing Taxane-Induced Neuropathy: The CryoPac Randomised Controlled Trial — Ann Oncol (PMID 42838271) | chemotherapy-and-toxic-neuropathy, clinical-trials-landscape |
| 2026-10-02 | Efficacy and Safety of Crisugabalin for Inadequately Controlled Diabetic Peripheral Neuropathic Pain: A Randomized, Active-Controlled, Phase 2 Trial — Diabetes Obes Metab (PMID 42823911) | diabetic-neuropathic-pain |
| 2026-10-01 | Herpes Zoster Vaccination in Patients with Immune-Mediated Inflammatory Diseases: A Systematic Review and Meta-Analysis of Vaccine Efficacy, Effectiveness, and Safety — Int J Infect Dis (PMID 42896729) | postherpetic-and-postsurgical-pain |
| 2026-10-01 | Longitudinal plasma phosphorylated neurofilament-heavy chain levels in oxaliplatin-induced peripheral neuropathy: a prospective multi-institutional exploratory study — Cancer Chemother Pharmacol (PMID 42873277) | chemotherapy-and-toxic-neuropathy |
| 2026-09-09 | Preventive effect of goshajinkigan on paclitaxel-induced peripheral neuropathy: an open-label, randomized phase II study (OLCSG2101) — Oncologist (PMID 42750137) | chemotherapy-and-toxic-neuropathy |
| 2026-09-04 | Prevalence and Study-Level Predictors of Chronic Chemotherapy-Induced Peripheral Neuropathy: A Systematic Review and Meta-Analysis — J Pain Res (PMID 42713463) | chemotherapy-and-toxic-neuropathy, epidemiology-and-burden |
| 2026-09-03 | Evaluation of the efficacy of duloxetine and venlafaxine in chemotherapy-induced neuropathy in cancer patients: a double-blind multicenter randomized clinical trial — Ann Med Surg (Lond) (PMID 42866777) | chemotherapy-and-toxic-neuropathy |
| 2026-09-03 | Multifactorial Contributors to Dose Limiting and Post-Treatment Neurologic Toxicity During Chemotherapy Treatment — Neurology (PMID 42814908) | chemotherapy-and-toxic-neuropathy |
…and 9 more in the last 3 months — see the full recency page.
Rheumatoid arthritis¶
last week: 0 · last month: 2 · last 2 months: 15 · last 3 months: 18 · last 6 months: 28 · last year: 40 · 282 cited in total · full recency page
Published in the last 3 months:
| Published | Paper | Cited on |
|---|---|---|
| 2026-10-06 | Outcomes of Tapering Biologic and Targeted Synthetic Disease-Modifying Antirheumatic Drugs in Rheumatoid Arthritis: A Multicenter Randomized Noninferiority Trial — Arthritis Rheumatol (PMID 42839723) | treat-to-target-and-remission |
| 2026-10-02 | Ex vivo JAK and TNF inhibitor-modulated immune signatures guide first-line therapy selection in rheumatoid arthritis — Biomark Res (PMID 42907925) | biomarkers-and-tissue-precision |
| 2026-10-01 | Efficacy of tapering biologics and JAK inhibitors in rheumatoid arthritis: A systematic review and meta-analysis — Reumatol Clin (Engl Ed) (PMID 42963167) | jak-inhibitors-and-targeted-therapy, treat-to-target-and-remission |
| 2026-10-01 | Divergent approaches to rheumatoid arthritis-associated interstitial lung disease: a comparative analysis of international clinical practice guidelines — Rheumatol Int (PMID 42888356) | guidelines |
| 2026-10-01 | Senescent-like activated naive B cells contribute to progression to clinical rheumatoid arthritis — Nat Aging (PMID 42875583) | preclinical-autoimmunity-and-prevention |
| 2026-10-01 | Lung ultrasound as part of a diagnostic algorithm to detect interstitial lung disease in rheumatoid arthritis patients at risk — Clin Exp Rheumatol (PMID 42873714) | ra-associated-interstitial-lung-disease |
| 2026-10-01 | JAK Inhibitor Cycling Shows Higher Drug Retention than Biologic Switching Following First JAK Inhibitor Failure in Rheumatoid Arthritis — Joint Bone Spine (PMID 42869207) | difficult-to-treat-and-refractory-ra |
| 2026-10-01 | Temporal Patterns of Outcomes After DMARD Tapering or Withdrawal in Rheumatoid Arthritis With Sustained Disease Control: A Systematic Review and Meta-Analysis — Clin Transl Sci (PMID 42836514) | treat-to-target-and-remission |
| 2026-10-01 | Comparative Safety of JAK versus TNF Inhibitors in Older Adults with Rheumatoid Arthritis: A Propensity Score-Matched Cohort Study — J Rheumatol (PMID 42823079) | jak-inhibitors-and-targeted-therapy |
| 2026-10-01 | First-line biologic and targeted synthetic DMARDs versus methotrexate in early rheumatoid arthritis: a meta-analysis of remission outcomes — Rheumatology (Oxford) (PMID 42755040) | biologic-dmards |
…and 8 more in the last 3 months — see the full recency page.
Type 2 diabetes¶
last week: 0 · last month: 6 · last 2 months: 16 · last 3 months: 18 · last 6 months: 22 · last year: 32 · 265 cited in total · full recency page
Published in the last 3 months:
| Published | Paper | Cited on |
|---|---|---|
| 2026-10-17 | Department of Error — Lancet (PMID 42880309) | incretin-therapies |
| 2026-10-02 | Correction: Management of type 2 diabetes, 2026. A consensus report by the American Diabetes Association (ADA) and the European Association for the Study of Diabetes (EASD) — Diabetologia (PMID 42955083) | guidelines |
| 2026-10-02 | A Malaysian Expert Consensus on The Identification, Evaluation, and Pharmacological Management of Diabetic Sensorimotor Polyneuropathy — Diabetes Ther (PMID 42928304) | guidelines |
| 2026-10-02 | Search for the glycated hemoglobin target minimizing mortality among people with type 2 diabetes with rare incidence of treatment-related severe hypoglycemia - Epidemiologic analysis of J-DOIT3 randomized controlled trial — PLoS One (PMID 42912779) | glycemic-management-and-legacy-trials |
| 2026-10-02 | Predictors of Type 2 Diabetes Remission and Relapse After Metabolic-Bariatric Surgery or Medical-Lifestyle Therapy in the ARMMS-T2D Study — Diabetes Care (PMID 42900776) | metabolic-surgery |
| 2026-10-02 | Management of Type 2 Diabetes, 2026. A Consensus Report by the American Diabetes Association (ADA) and the European Association for the Study of Diabetes (EASD) — Diabetes Care (PMID 42825450) | guidelines |
| 2026-10-01 | A Conversation Tool to Enhance Care for People With Type 2 Diabetes: The QBSafe Cluster Randomized Clinical Trial — JAMA Netw Open (PMID 42895748) | clinical-trials-landscape |
| 2026-10-01 | Continuous Glucose Monitoring in Non-Insulin-Treated Type 2 Diabetes — N Engl J Med (PMID 42878622) | clinical-trials-landscape, glycemic-management-and-legacy-trials |
| 2026-10-01 | Survodutide Once Weekly in Adults with Obesity and Type 2 Diabetes — N Engl J Med (PMID 42820639) | clinical-trials-landscape, incretin-therapies |
| 2026-09-03 | Cardiovascular safety of orforglipron versus insulin glargine in adults with type 2 diabetes at increased cardiovascular risk (ACHIEVE-4): a phase 3, event-driven, randomised, open-label, non-inferiority, active comparator trial — Lancet (PMID 42815506) | clinical-trials-landscape, incretin-therapies |
…and 8 more in the last 3 months — see the full recency page.
Ptsd¶
last week: 0 · last month: 6 · last 2 months: 18 · last 3 months: 18 · last 6 months: 22 · last year: 30 · 421 cited in total · full recency page
Published in the last 3 months:
| Published | Paper | Cited on |
|---|---|---|
| 2026-10-08 | Treatment of PTSD in the military health system: Which patients receive evidence based psychotherapy? — Psychiatry Res (PMID 42906525) | military-and-veteran-populations |
| 2026-10-07 | Efficacy and safety of ketamine for post-traumatic stress disorder: A systematic review with narrative synthesis and consideration of military and veteran populations — PCN Rep (PMID 42846850) | pharmacotherapy |
| 2026-10-05 | Benzodiazepine prescribing in chronic military-related PTSD: real-world patterns and correlates in specialized care — Front Psychiatry (PMID 42898444) | red-flags-and-safety-concerns |
| 2026-10-05 | Systematic review and meta-analysis: the effectiveness of cognitive behavioral therapy and eye movement desensitization and reprocessing in children and adolescents — Eur J Psychotraumatol (PMID 42831259) | children-and-adolescents |
| 2026-10-02 | Examining the performance of the International Trauma Questionnaire with clinical checks in a multinational European sample — PLoS One (PMID 42905693) | diagnosis-and-classification |
| 2026-10-02 | Complex post-traumatic stress disorder in refugees, asylum seekers, and internally displaced people: a systematic review and meta-analysis — Eur J Psychotraumatol (PMID 42900526) | complex-ptsd |
| 2026-10-01 | Clinical Evidence on Psilocybin and Its Representation in Media Reporting: A Systematic Review — JAMA Netw Open (PMID 42900476) | mdma-and-psychedelic-assisted-therapy |
| 2026-10-01 | A living systematic review, meta-analysis, and open data resource of trials of MDMA-assisted therapy for PTSD — Neuropsychopharmacology (PMID 42860436) | mdma-and-psychedelic-assisted-therapy |
| 2026-10-01 | Online stepped care for the treatment of posttraumatic stress disorder: A randomized controlled noninferiority trial — Behav Res Ther (PMID 42832930) | dropout-and-nonresponse |
| 2026-10-01 | Multi-center, randomized controlled efficacy and comparative-effectiveness study evaluating ketamine, stellate ganglion blocks, combination treatment, and sham treatments for posttraumatic stress disorder and traumatic brain injury-associated headache: a study protocol — Pain Manag (PMID 42817839) | clinical-trials-landscape |
…and 8 more in the last 3 months — see the full recency page.
Chronic kidney disease¶
last week: 0 · last month: 7 · last 2 months: 15 · last 3 months: 17 · last 6 months: 29 · last year: 49 · 329 cited in total · full recency page
Published in the last 3 months:
| Published | Paper | Cited on |
|---|---|---|
| 2026-10-09 | A Microsimulation of Eligibility for Cardiorenal Combination Treatment and Potential Deaths Averted — J Am Soc Nephrol (PMID 42853614) | clinical-trials-landscape |
| 2026-10-02 | Empagliflozin Therapy in Autosomal Dominant Polycystic Kidney Disease: A Feasibility Randomized Controlled Trial — J Am Soc Nephrol (PMID 42925875) | clinical-trials-landscape, inherited-and-glomerular-disease, sglt2-inhibitors |
| 2026-10-02 | Ravulizumab in IgA Nephropathy - Interim Analysis of a Phase 3 Trial — N Engl J Med (PMID 42912700) | clinical-trials-landscape, inherited-and-glomerular-disease |
| 2026-10-02 | Interim Analysis of a Phase 3 Trial of Povetacicept in IgA Nephropathy — N Engl J Med (PMID 42912669) | clinical-trials-landscape, inherited-and-glomerular-disease |
| 2026-10-02 | Video Decision Support and Advance Care Planning in Older Adults With Advanced Kidney Disease: The VIDEO-KD Randomized Clinical Trial — JAMA Intern Med (PMID 42911803) | conservative-and-supportive-care |
| 2026-10-02 | Sibeprenlimab in IgA Nephropathy - Final Phase 3 Trial Analysis — N Engl J Med (PMID 42911185) | clinical-trials-landscape, inherited-and-glomerular-disease |
| 2026-10-02 | Atacicept in IgA Nephropathy - Phase 3 Trial Final Efficacy Analysis — N Engl J Med (PMID 42911181) | clinical-trials-landscape, inherited-and-glomerular-disease |
| 2026-10-01 | Validation of the Klinrisk CKD Progression Model in the Dapagliflozin and Prevention of Adverse Outcomes in CKD (DAPA-CKD) Population — Kidney360 (PMID 42868053) | risk-prediction-and-prognosis |
| 2026-10-01 | Haemodiafiltration, haemofiltration and haemodialysis for adults with kidney failure — Cochrane Database Syst Rev (PMID 42867023) | kidney-replacement-therapy-decisions |
| 2026-10-01 | Effects of semaglutide on kidney disease in type 2 diabetes: a randomized placebo-controlled trial — Nat Med (PMID 42823485) | clinical-trials-landscape, glp1-and-emerging-therapy, pathophysiology-and-progression |
…and 7 more in the last 3 months — see the full recency page.
Type 1 diabetes¶
last week: 0 · last month: 2 · last 2 months: 15 · last 3 months: 17 · last 6 months: 24 · last year: 39 · 276 cited in total · full recency page
Published in the last 3 months:
| Published | Paper | Cited on |
|---|---|---|
| 2026-10-02 | Population-Based Screening for Type 1 Diabetes in Czechia: Results From the First 1% of the Paediatric Population — Diabetes Obes Metab (PMID 42935169) | screening-and-early-detection |
| 2026-10-02 | Maternal Autoimmune Diseases During Pregnancy and Offspring Type 1 Diabetes — JAMA Pediatr (PMID 42931746) | genetics-and-environmental-triggers |
| 2026-10-01 | Maternal antibody transfer confounds type 1 diabetes screening in infancy: results from the French TRAKR cohort — Diabetes Metab (PMID 42880695) | screening-and-early-detection |
| 2026-10-01 | Predictive autoantibodies before the diagnosis of type I diabetes in adults — PLoS One (PMID 42879429) | staging-and-natural-history |
| 2026-10-01 | Fulminant Secondary HLH Following EBV Reactivation in an Adult With Trisomy 21 After Teplizumab Treatment for Stage 2 Type 1 Diabetes — Diabetes Care (PMID 42520060) | disease-modifying-immunotherapy |
| 2026-09-03 | Correction: The management of type 1 diabetes in adults. The updated 2026 consensus report by the American Diabetes Association (ADA) and the European Association for the Study of Diabetes (EASD) — Diabetologia (PMID 42814152) | guidelines |
| 2026-09-03 | Gene-edited hypoimmune islets as a cure for type 1 diabetes: a review of the immunological challenges — Expert Opin Biol Ther (PMID 42626948) | beta-cell-replacement |
| 2026-09-02 | Delayed time to stage 3 type 1 diabetes after GAD-alum treatment in HLA-DR3-DQ2-positive children: follow-up of the randomised placebo-controlled Diabetes Prevention - Immune Tolerance trial — Diabetologia (PMID 42806034) | disease-modifying-immunotherapy |
| 2026-09-02 | An international position statement on practical approaches for inpatient continuous glucose monitoring, insulin pumps and automated insulin delivery systems in adults — Diabetologia (PMID 42771181) | guidelines, insulin-therapy-and-technology |
| 2026-09-01 | Acute eGFR Changes With Finerenone Examined in a Prespecified Analysis of FINE-ONE — Kidney Int Rep (PMID 42927222) | complications |
…and 7 more in the last 3 months — see the full recency page.
Hepatocellular carcinoma¶
last week: 1 · last month: 3 · last 2 months: 15 · last 3 months: 17 · last 6 months: 19 · last year: 24 · 347 cited in total · full recency page
Published in the last 3 months:
| Published | Paper | Cited on |
|---|---|---|
| 2026-11-01 | The aMAP Score Effectively Stratifies Hepatocellular Carcinoma Risk in the Steatotic Liver Disease Population — Liver Int (PMID 42904608) | mash-masld-hcc |
| 2026-10-09 | Inequalities in hepatocellular carcinoma (HCC) surveillance uptake in London: a UK multicentre cohort study — BMJ Public Health (PMID 42866364) | surveillance-and-early-detection |
| 2026-10-06 | First-line durvalumab and tremelimumab in poor-prognosis unresectable hepatocellular carcinoma: Phase IIIb single-arm SIERRA study — J Hepatol (PMID 42838226) | systemic-therapy |
| 2026-10-01 | NCCN Guidelines® Insights: Hepatocellular Carcinoma, Version 2.2026 — J Natl Compr Canc Netw (PMID 42874666) | guidelines |
| 2026-10-01 | Immune Checkpoint Inhibitor-Based Downstaging Therapy for Hepatocellular Carcinoma — JAMA Oncol (PMID 42821267) | liver-transplantation |
| 2026-10-01 | Correction to Lancet Oncol 2026; 27: 1077-93 — Lancet Oncol (PMID 42805209) | clinical-trials-landscape, guidelines, locoregional-therapy |
| 2026-10-01 | Global burden of cancer attributable to infections in 2024: a worldwide incidence analysis — Lancet Oncol (PMID 42805198) | epidemiology-and-etiology |
| 2026-09-06 | Circulating tumor DNA and recurrence after curative-intent treatment of hepatocellular carcinoma: A systematic review and meta-analysis — Surg Oncol (PMID 42715861) | biomarkers |
| 2026-09-03 | IHPBA 2026 global guideline for the management of hepatocellular carcinoma in resource-constrained healthcare settings — HPB (Oxford) (PMID 42869716) | guidelines |
| 2026-09-02 | Multi-target blood test for hepatocellular carcinoma early detection: A cross-sectional analysis of the prospective ALTUS study — J Hepatol (PMID 42800682) | biomarkers, surveillance-and-early-detection |
…and 7 more in the last 3 months — see the full recency page.
Osteoarthritis¶
last week: 0 · last month: 3 · last 2 months: 13 · last 3 months: 16 · last 6 months: 31 · last year: 59 · 557 cited in total · full recency page
Published in the last 3 months:
| Published | Paper | Cited on |
|---|---|---|
| 2026-10-15 | American Academy of Orthopaedic Surgeons Clinical Practice Guideline Summary: Management of Osteoarthritis of the Hip: Erratum — J Am Acad Orthop Surg (PMID 42825586) | guidelines |
| 2026-10-15 | AAOS Clinical Practice Guideline Summary: Management of Osteoarthritis of the Knee (Nonarthroplasty), Third Edition: Erratum — J Am Acad Orthop Surg (PMID 42825585) | guidelines |
| 2026-10-02 | Platelet-rich plasma for knee osteoarthritis: a systematic review and meta-analysis of structural outcomes — Arch Orthop Trauma Surg (PMID 42918921) | injections-and-orthobiologics |
| 2026-10-01 | Technique, Safety and Adoption of Genicular Artery Embolization for Knee Osteoarthritis: A Nationwide Analysis of the German Quality-Assurance Registry — Cardiovasc Intervent Radiol (PMID 42897320) | injections-and-orthobiologics |
| 2026-10-01 | Additional Effects of Manual Therapy to Exercise on Pain and Function in Individuals With Knee Osteoarthritis: A Systematic Review and Meta-Analysis — Eur J Pain (PMID 42885413) | exercise-weight-and-self-management |
| 2026-10-01 | Sex differences in clinical need, willingness, and surgeon recommendations for total knee arthroplasty: a cross-sectional study — J Rheumatol (PMID 42880894) | surgery-and-joint-replacement |
| 2026-09-03 | Comparative effectiveness of exercise and self-management interventions delivered through different modes of digital support on pain and patient-reported physical function in people with knee osteoarthritis: a systematic review and network meta-analysis of randomised controlled trials — Front Med (Lausanne) (PMID 42876545) | exercise-weight-and-self-management |
| 2026-09-02 | Retatrutide, a Triple Hormone Receptor Agonist, for Treatment of Obesity — N Engl J Med (PMID 42814954) | clinical-trials-landscape, exercise-weight-and-self-management |
| 2026-09-02 | Can obesity pharmacotherapy modify osteoarthritis? Interpreting pain relief, weight-loss quality, and structural outcomes — Osteoarthritis Cartilage (PMID 42767324) | exercise-weight-and-self-management |
| 2026-09-01 | Efficacy and Safety of Tofacitinib Versus Placebo in Patients With Early-Grade Knee Osteoarthritis: A Randomized, Double-Blind, Placebo-Controlled Trial — Int J Rheum Dis (PMID 42760593) | disease-modifying-therapies |
…and 6 more in the last 3 months — see the full recency page.
Thoracic aortic aneurysm¶
last week: 0 · last month: 5 · last 2 months: 14 · last 3 months: 16 · last 6 months: 21 · last year: 34 · 359 cited in total · full recency page
Published in the last 3 months:
| Published | Paper | Cited on |
|---|---|---|
| 2026-10-02 | Circulating Lipids, Statins, and Metformin in Thoracic and Abdominal Aortic Aneurysm: A Systematic Review and Meta-Analysis — Life (Basel) (PMID 42942351) | medical-therapy |
| 2026-10-02 | Early Outcomes of Thoracic Branch Endoprosthesis in Aortic Arch Pathologies: A Nordic Multicentre Study — Eur J Vasc Endovasc Surg (PMID 42913781) | clinical-trials-landscape, surgical-and-endovascular-repair |
| 2026-10-02 | Multidisciplinary Collaboration in the Performance of Aortic Surgery: A Scientific Statement From the American Heart Association — Circulation (PMID 42910416) | guidelines |
| 2026-10-02 | Adiposity and the risk of aortic dissection incidence and mortality: results from the UK Biobank, the J-SHC study and a meta-analysis of cohort studies — Eur J Epidemiol (PMID 42902107) | epidemiology-and-natural-history |
| 2026-10-02 | Maternal and neonatal outcomes in Marfan syndrome: a nationwide registry — Heart (PMID 41475970) | red-flags-and-safety-concerns |
| 2026-10-01 | Divergent aortic root cusp-to-cusp measurement techniques on CMR: geometric implications and threshold reclassification — Eur Heart J Imaging Methods Pract (PMID 42890866) | imaging-and-surveillance |
| 2026-10-01 | Lived experiences of post-traumatic growth in patients with acute type A aortic dissection: A qualitative study — PLoS One (PMID 42879453) | patient-experience-and-advocacy |
| 2026-10-01 | 1-Year Outcomes of Endovascular Repair of Zone 0/1 Aortic Arch Lesions with a Thoracic Branched Endoprosthesis — Ann Thorac Surg (PMID 42863733) | clinical-trials-landscape, surgical-and-endovascular-repair |
| 2026-09-03 | Clinical Considerations for the Care of the Tactical Athlete With Cardiovascular Abnormalities: A Scientific Statement From the American College of Cardiology and the American Heart Association — Circulation (PMID 42691142) | guidelines |
| 2026-09-02 | Genetic Patterns in Familial Thoracic Aortic Aneurysm Disease — Genes (Basel) (PMID 42938321) | epidemiology-and-natural-history, genetics-of-taa |
…and 6 more in the last 3 months — see the full recency page.
Irritable bowel syndrome¶
last week: 0 · last month: 0 · last 2 months: 13 · last 3 months: 15 · last 6 months: 24 · last year: 47 · 381 cited in total · full recency page
Published in the last 3 months:
| Published | Paper | Cited on |
|---|---|---|
| 2026-10-01 | Epidemiology of Irritable Bowel Syndrome Among Chilean Adults: Differences Across Healthcare Settings and Urban-Rural Populations — Neurogastroenterol Motil (PMID 42928586) | epidemiology-and-burden |
| 2026-10-01 | A Genome-Wide Meta-Analysis of Functional Dyspepsia in 1,168,899 Individuals Implicates Immune Pathways in Disease Susceptibility — Neurogastroenterol Motil (PMID 42897685) | overlap-with-functional-dyspepsia |
| 2026-10-01 | When Food Avoidance Meets Compatible Diagnostic Criteria: Avoidant/Restrictive Food Intake Disorder Features in Irritable Bowel Syndrome — Neurogastroenterol Motil (PMID 42823900) | dietary-therapy, red-flags-and-safety-concerns |
| 2026-09-08 | No robust cortical morphometry differences and limited morphometry-phenotype associations in a UK Biobank irritable bowel syndrome phenotype — Neuroimage (PMID 42710640) | brain-gut-axis-and-visceral-hypersensitivity |
| 2026-09-07 | Disordered Eating Behaviors Many Years After Education in a Low FODMAP Diet in Patients With Irritable Bowel Syndrome — JGH Open (PMID 42712718) | dietary-therapy, red-flags-and-safety-concerns |
| 2026-09-07 | Rome V global epidemiology and validation survey: prevalence of disorders of gut-brain interaction and comparison with the Rome IV global epidemiology study — Gut (PMID 42613194) | diagnosis-and-rome-criteria, epidemiology-and-burden, overlap-with-functional-dyspepsia, overview |
| 2026-09-04 | Mortality in Irritable Bowel Syndrome: The Tohoku Medical Megabank Project Community-based Cohort Study — J Neurogastroenterol Motil (PMID 42702587) | epidemiology-and-burden |
| 2026-09-03 | Argentine consensus on the clinical utility of breath tests and small intestinal bacterial overgrowth management in patients with disorders of gut-brain interaction — Rev Gastroenterol Mex (Engl Ed) (PMID 42816255) | guidelines |
| 2026-09-02 | Faecal microbiota transplantation in irritable bowel syndrome (REFIT2): a randomised, double-blind, placebo-controlled, phase 3 trial — Lancet (PMID 42785338) | clinical-trials-landscape, microbiome |
| 2026-09-02 | Healthy donor faecal microbiota transplantation in irritable bowel syndrome: interpreting negative findings — Lancet (PMID 42785337) | microbiome |
…and 5 more in the last 3 months — see the full recency page.
Cataracts¶
last week: 0 · last month: 2 · last 2 months: 15 · last 3 months: 15 · last 6 months: 19 · last year: 42 · 465 cited in total · full recency page
Published in the last 3 months:
| Published | Paper | Cited on |
|---|---|---|
| 2026-10-02 | Artificial intelligence across the cataract care continuum: a systematic scoping review introducing the CAICC framework and the surgical complexity prediction gap — BMC Ophthalmol (PMID 42958114) | classification-and-grading |
| 2026-10-02 | Endophthalmitis after cataract surgery in Sweden 2018-2024: associations with preoperative visual acuity and intracameral antibiotic regimens — Br J Ophthalmol (PMID 42833872) | complications |
| 2026-10-01 | Congenital cataract in children: Age at surgery and diagnosis-treatment interval in the Brazilian Unified Health System in Salvador (BA), Brazil — Rev Paul Pediatr (PMID 42912061) | congenital-and-paediatric-cataract |
| 2026-10-01 | Air pollution exposure and cataract outcomes: a systematic review and pollutant-specific meta-analysis — Front Med (Lausanne) (PMID 42889176) | risk-factors |
| 2026-10-01 | Association Between Cataract Diagnosis and Depressive Symptoms in Peruvian Adults Aged 50 Years and Older: Analysis of a Nationally Representative Survey — Ophthalmic Epidemiol (PMID 42869632) | patient-experience-and-advocacy |
| 2026-10-01 | Risk of Endophthalmitis After Cataract Surgery in Immunosuppressed Patients — Ophthalmic Surg Lasers Imaging Retina (PMID 42862931) | complications, red-flags-and-safety-concerns |
| 2026-10-01 | Aqueous chlorhexidine versus povidone-iodine for ocular antisepsis: A systematic review and meta-analysis — Acta Ophthalmol (PMID 42820391) | complications, guidelines |
| 2026-10-01 | Patient-reported outcome measures in cataract surgery: systematic review and meta-analysis of visual function and quality of life — Can J Ophthalmol (PMID 42686107) | outcomes-and-quality-of-life |
| 2026-10-01 | Incidence of secondary intraocular lens implantation in school-aged children left aphakic to age 4.5 years in the Infant Aphakia Treatment Study — J Cataract Refract Surg (PMID 41962549) | congenital-and-paediatric-cataract |
| 2026-09-02 | Effect of Preoperative Ocular Surface Optimization on Biometric Accuracy and Refractive Outcomes After Cataract Surgery: A Systematic Review with Narrative and Exploratory Quantitative Synthesis — Clin Ophthalmol (PMID 42807918) | diagnosis-and-preoperative-assessment |
…and 5 more in the last 3 months — see the full recency page.
Colorectal adenocarcinoma¶
last week: 0 · last month: 6 · last 2 months: 14 · last 3 months: 15 · last 6 months: 26 · last year: 33 · 319 cited in total · full recency page
Published in the last 3 months:
| Published | Paper | Cited on |
|---|---|---|
| 2026-10-02 | Clinical Complete Response with Dostarlimab Monotherapy in dMMR/MSI-H Locally Advanced Rectal Cancer: First Results from the Global AZUR-1 Trial — Ann Oncol (PMID 42927858) | clinical-trials-landscape, localized-rectal-cancer |
| 2026-10-02 | A randomised phase III trial of adjuvant treatment intensification with mFOLFIRINOX versus mFOLFOX6 in high-risk stage III colon cancer: Results of the international IROCAS study — Ann Oncol (PMID 42927853) | clinical-trials-landscape, localized-colon-cancer |
| 2026-10-02 | Neoadjuvant short-course radiotherapy followed by camrelizumab and chemotherapy versus standard of care for locally advanced rectal cancer (UNION): a prespecified interim analysis of a multicentre, open-label, randomised, phase 3 trial — Lancet Oncol (PMID 42927765) | clinical-trials-landscape, localized-rectal-cancer |
| 2026-10-02 | Final results of nivolumab plus ipilimumab versus nivolumab or chemotherapy in microsatellite instability-high/mismatch repair-deficient metastatic colorectal cancer from CheckMate 8HW — Ann Oncol (PMID 42926106) | clinical-trials-landscape, metastatic-systemic-therapy, precision-oncology |
| 2026-10-02 | 14-day versus 28-day trifluridine-tipiracil plus bevacizumab for refractory metastatic colorectal cancer (PRABITAS): a pragmatic, multicentre, open-label, randomised, phase 3, non-inferiority trial in Japan — Lancet (PMID 42925880) | metastatic-systemic-therapy |
| 2026-10-02 | Disease-free survival and overall survival after neoadjuvant immunotherapy in mismatch repair-deficient colon cancer in the Netherlands: results of the single-arm, multicentre, phase 2, NICHE-2 trial — Lancet (PMID 42906564) | clinical-trials-landscape, localized-colon-cancer |
| 2026-09-17 | Colonoscopy Intervals and Colorectal Cancer Incidence after Adenoma Removal — N Engl J Med (PMID 42748427) | screening-and-early-detection |
| 2026-09-03 | Serrated Polyposis Syndrome: A Review and Consensus Statement by the US Multi-Society Task Force on Colorectal Cancer — Gastroenterology (PMID 42814045) | guidelines |
| 2026-09-02 | Microwave ablation versus stereotactic body radiotherapy for oligometastatic colorectal liver metastases (LAVA-CRLM): a prospective, randomised, phase II trial — Lancet Reg Health Eur (PMID 42829779) | liver-and-lung-metastasis |
| 2026-09-02 | Erratum: Five-Year Outcomes of Short-Term Radiotherapy Plus Chemotherapy Versus Long-Term Chemoradiotherapy for Locally Advanced Rectal Cancer: Updated Results of the STELLAR Trial — J Clin Oncol (PMID 42789827) | localized-rectal-cancer |
…and 5 more in the last 3 months — see the full recency page.
COPD¶
last week: 0 · last month: 2 · last 2 months: 13 · last 3 months: 15 · last 6 months: 19 · last year: 24 · 316 cited in total · full recency page
Published in the last 3 months:
| Published | Paper | Cited on |
|---|---|---|
| 2026-10-02 | CONQUEST-ADVANCE: Achieving proDuctiVe implementAtioN of CONQUEST Quality Standards in COPD Care — Pragmat Obs Res (PMID 42928880) | guidelines |
| 2026-10-02 | Comparative Real-World Effectiveness of Dupilumab, Mepolizumab, and Benralizumab in Patients with Chronic Obstructive Pulmonary Disease: A Propensity Score-Matched Cohort Study — Drug Des Devel Ther (PMID 42928777) | clinical-trials-landscape |
| 2026-10-01 | Needs among persons with advanced COPD and their informal caregivers: a multi-perspective qualitative study focusing on the potential role of palliative care — BMC Pulm Med (PMID 42897575) | patient-experience-and-advocacy |
| 2026-09-09 | AARC Clinical Practice Guideline: Adult Patients Transitioning From the Hospital on Oxygen — Respir Care (PMID 42713935) | oxygen-and-ventilatory-support |
| 2026-09-08 | Tozorakimab to Prevent COPD Exacerbations — N Engl J Med (PMID 42708515) | clinical-trials-landscape, guidelines |
| 2026-09-06 | Metoprolol in Chronic Obstructive Pulmonary Disease without Cardiovascular Disease — NEJM Evid (PMID 42701865) | comorbidity-and-systemic-effects, guidelines |
| 2026-09-03 | Extracorporeal CO(2) elimination for acute exacerbation of severe COPD requiring invasive mechanical ventilation: a randomized controlled trial (the X-COPD trial) — Crit Care (PMID 42693471) | exacerbations-and-acute-care |
| 2026-09-02 | Metered-Dose Liquid Nitrogen Cryospray for Chronic Bronchitis: Results From the Prospective, Sham-Controlled Trial (SPRAY-CB) — Am J Respir Crit Care Med (PMID 42768446) | emphysema-procedures-and-transplant |
| 2026-09-02 | Portable low-flow nasal oxygen versus ambient air in patients with chronic lung disease and exercise-induced hypoxaemia: a randomised controlled crossover non-inferiority trial — BMJ Open Respir Res (PMID 42767802) | oxygen-and-ventilatory-support |
| 2026-09-01 | Mepolizumab efficacy in chronic obstructive pulmonary disease: insights from longitudinal patterns of blood eosinophil counts and their variability across 3 clinical trials — Am J Respir Crit Care Med (PMID 42265988) | clinical-trials-landscape |
…and 5 more in the last 3 months — see the full recency page.
Masld¶
last week: 3 · last month: 6 · last 2 months: 11 · last 3 months: 13 · last 6 months: 18 · last year: 48 · 373 cited in total · full recency page
Published in the last 3 months:
| Published | Paper | Cited on |
|---|---|---|
| 2026-11-01 | Taiwan GEST-TASL-TMASO Joint Position Statement in Managing Metabolic Dysfunction-Associated Steatotic Liver Disease and Obesity — Liver Int (PMID 42922180) | guidelines |
| 2026-11-01 | The aMAP Score Effectively Stratifies Hepatocellular Carcinoma Risk in the Steatotic Liver Disease Population — Liver Int (PMID 42904608) | masld-related-hepatocellular-carcinoma |
| 2026-11-01 | Understanding MASLD and diabetes through lived experience — Diabetologia (PMID 42525136) | patient-experience-and-advocacy |
| 2026-10-02 | The Madrid Declaration on metabolic dysfunction-associated steatotic liver disease (MASLD). Innovation, equity, and transformation of the health-system response to the metabolic disease challenge of the 21st century — Rev Esp Enferm Dig (PMID 42929259) | guidelines |
| 2026-10-02 | Patients with MASH experience worse health-related quality of life: a multinational real-world study using LiverMultiScan — Qual Life Res (PMID 42911297) | patient-experience-and-advocacy |
| 2026-10-02 | Genome-wide analyses identify 60 loci associated with liver triglyceride content — Nat Genet (PMID 42907524) | genetics |
| 2026-10-01 | Gaps in awareness of metabolic liver disease among high-risk populations in the United States — Hepatol Commun (PMID 42900157) | patient-experience-and-advocacy |
| 2026-10-01 | Phase 2 study of fazpilodemab, a FGFR1/Klothoβ agonist, in metabolic dysfunction-associated steatohepatitis (MASH) — JHEP Rep (PMID 42892346) | other-pharmacotherapy |
| 2026-10-01 | Thyroid hormone receptor-β agonist simedeutirom (HSK31679) for Chinese patients with metabolic dysfunction-associated steatohepatitis: a 52-week, multicentre, randomised, double-blind, placebo-controlled, phase 2b trial — Lancet Gastroenterol Hepatol (PMID 42887516) | clinical-trials-landscape, resmetirom-and-thyromimetics |
| 2026-10-01 | Characteristics and outcomes of lean versus non-lean metabolic dysfunction-associated steatohepatitis liver transplant recipients — Ann Hepatol (PMID 42869334) | lean-masld |
…and 3 more in the last 3 months — see the full recency page.
Vascular dementia¶
last week: 0 · last month: 6 · last 2 months: 12 · last 3 months: 13 · last 6 months: 18 · last year: 38 · 431 cited in total · full recency page
Published in the last 3 months:
| Published | Paper | Cited on |
|---|---|---|
| 2026-10-09 | Centrum Semiovale Perivascular Spaces Predict First Hemorrhagic Lesion in Asymptomatic Amyloid-Positive Individuals — Ann Neurol (PMID 42855813) | cerebral-amyloid-angiopathy |
| 2026-10-06 | Head-to-head comparison of diffusion imaging markers for cognitive decline and risk of dementia: The population-based Rotterdam Study — Imaging Neurosci (Camb) (PMID 42846338) | neuroimaging |
| 2026-10-05 | Interventions to reduce cognitive decline post-stroke: an umbrella review — Eur Stroke J (PMID 42886840) | treatment |
| 2026-10-03 | Visual rating versus volumetric segmentation of white matter hyperintensities for cognitive assessment: a memory clinic-based comparison and systematic review — Cereb Circ Cogn Behav (PMID 42898208) | neuroimaging |
| 2026-10-02 | Dose-response relationship of exercise intervention on cognitive function in patients with stroke: a systematic review and meta-analysis — Top Stroke Rehabil (PMID 42912759) | treatment |
| 2026-10-02 | Neuropsychiatric symptoms in vascular cognitive impairment: A comparative study between CADASIL and sporadic small vessel disease — J Formos Med Assoc (PMID 42907303) | cognitive-profile-and-assessment, monogenic-and-inherited-forms |
| 2026-10-01 | Location matters: Attributing cognitive symptoms to white matter hyperintensities in 3,481 memory clinic patients — Dement Geriatr Cogn Disord (PMID 42895925) | neuroimaging, subtypes-and-clinical-syndromes |
| 2026-10-01 | Vascular dementia and vascular cognitive impairment-current treatments and future prospects — Int J Stroke (PMID 42894468) | treatment |
| 2026-10-01 | Pericyte loss and endothelial activation define distinct vascular states in cerebral small vessel disease — Acta Neuropathol (PMID 42867637) | pathophysiology |
| 2026-10-01 | Longitudinal associations between physical activity and cognition post-stroke: the Nor-COAST study — Brain Commun (PMID 42865713) | treatment |
…and 3 more in the last 3 months — see the full recency page.
Generalized anxiety disorder¶
last week: 0 · last month: 3 · last 2 months: 11 · last 3 months: 11 · last 6 months: 14 · last year: 26 · 405 cited in total · full recency page
Published in the last 3 months:
| Published | Paper | Cited on |
|---|---|---|
| 2026-10-08 | Time to generalized anxiety disorder onset after substance use disorder: a survival analysis from a national sample — Psychiatry Res (PMID 42868720) | comorbidity-and-primary-care |
| 2026-10-08 | DT120 (MM120): a single-dose orally disintegrating formulation of lysergide tartrate for generalized anxiety disorder — Expert Rev Neurother (PMID 42848417) | clinical-trials-landscape |
| 2026-10-02 | Psychiatric, Sociodemographic, and Community Belonging Correlates of Suicidal Ideation in Canada: Findings from the 2022 Mental Health and Access to Care Survey — Can J Psychiatry (PMID 42924883) | red-flags-and-safety-concerns |
| 2026-10-01 | Age-stratified signals and early onset of adverse events with pregabalin: a disproportionality analysis of the FDA adverse event reporting system — Front Med (Lausanne) (PMID 42889226) | red-flags-and-safety-concerns |
| 2026-10-01 | Estimates of Anxiety Symptoms Among US Adolescents — JAMA Pediatr (PMID 42862569) | epidemiology-and-burden |
| 2026-10-01 | Reconsidering the health-related burden of mental and physical disorders in the presence of comorbidity: evidence from China Mental Health Survey — Epidemiol Psychiatr Sci (PMID 42858455) | epidemiology-and-burden |
| 2026-09-03 | PrEgabalin for Treatment Resistant generalised Anxiety disorder (PETRA): study protocol for a double-blind randomised controlled trial set in the UK — Trials (PMID 42717383) | clinical-trials-landscape, pregabalin-benzodiazepines-and-others, treatment-resistant-gad |
| 2026-09-02 | The 39 symptoms of generalized anxiety disorder: Limited overlap among seven common GAD scales — J Anxiety Disord (PMID 42809893) | screening-and-measurement |
| 2026-09-02 | Irritability and Emotion Dysregulation Predict Escitalopram Response in Adolescents with Generalized Anxiety Disorder: A Secondary Analysis of a Randomized, Double-Blind, Placebo-Controlled Trial — J Child Adolesc Psychopharmacol (PMID 42773855) | special-populations |
| 2026-09-01 | Efficacy of prescription-eligible digital health applications for depression and generalized anxiety disorder in Germany: a systematic review and meta-analysis — Sci Rep (PMID 42728340) | digital-and-remote-delivery |
…and 1 more in the last 3 months — see the full recency page.
Melanoma¶
last week: 0 · last month: 4 · last 2 months: 9 · last 3 months: 10 · last 6 months: 28 · last year: 67 · 639 cited in total · full recency page
Published in the last 3 months:
| Published | Paper | Cited on |
|---|---|---|
| 2026-10-09 | Mohs vs. Wide Local Excision for Early-Stage (AJCC 0-II) Cutaneous Head and Neck Melanoma: A Meta-Analysis — Head Neck (PMID 42855971) | surgical-management-and-margins |
| 2026-10-07 | Impact of adjuvant therapy on melanoma-specific survival in elderly patients with high-risk resected melanoma: a multicenter international retrospective study — J Immunother Cancer (PMID 42849920) | special-populations |
| 2026-10-07 | U.S. Cancer-Specific Mortality Trends After Early Immune Checkpoint Inhibitor Approvals: An Ecological Synthetic-Control Study, 1999-2019 — Cancer Control (PMID 42842875) | epidemiology-and-global-burden |
| 2026-10-07 | Melanoma Prevention Among Children of Melanoma Survivors: A Randomized Clinical Trial — JAMA Dermatol (PMID 42842243) | risk-factors-and-prevention |
| 2026-10-01 | Exploring the risk of melanoma in people with Parkinson's disease: a systematic review and meta-analysis — Dermatology (PMID 42858286) | risk-factors-and-prevention |
| 2026-09-03 | Melanoma incidence in Norway, 1980-2024: a cohort study — Lancet Reg Health Eur (PMID 42861403) | epidemiology-and-global-burden |
| 2026-09-02 | Unmet needs and associated factors among patients with melanoma: a mixed-methods study — Front Public Health (PMID 42865452) | patient-experience-and-advocacy |
| 2026-09-02 | Encorafenib plus binimetinib in patients with BRAF-mutated melanoma brain metastases: Results from the BECARE (GEM-2002) trial — Neurooncol Adv (PMID 42852354) | brain-metastases |
| 2026-09-01 | Clinical factors associated with leptomeningeal disease in patients with melanoma brain metastasis — Neurooncol Adv (PMID 42841061) | brain-metastases |
| 2026-08-04 | A Multistep Immune-Competent Genetically Engineered Mouse Model Reveals Phenotypic Plasticity in Uveal Melanoma — Cancer Res (PMID 41661679) | uveal-melanoma |
Depression¶
last week: 0 · last month: 4 · last 2 months: 7 · last 3 months: 10 · last 6 months: 27 · last year: 43 · 395 cited in total · full recency page
Published in the last 3 months:
| Published | Paper | Cited on |
|---|---|---|
| 2026-10-02 | Single Intranasal Administration of the Psychedelic Mebufotenin for Treatment-Resistant Depression: A Randomized Clinical Trial — JAMA (PMID 42931733) | clinical-trials-landscape, psychedelics-and-novel-therapeutics |
| 2026-10-02 | Efficacy of Non-Invasive Brain Stimulation on the Treatment of Late Life Depression: A Systematic Review and Network Meta-Analysis — Acta Psychiatr Scand (PMID 42924478) | neuromodulation |
| 2026-10-02 | Multimodal Machine Learning-Based Prediction of Relapse in Major Depressive Disorder — JAMA Psychiatry (PMID 42905697) | biomarkers-and-treatment-prediction |
| 2026-10-02 | Copenhagen Magnetic Personalized Accelerated Brain Circuit Therapy (CoMPACT) trial: study protocol for a randomized, double-blinded, sham-controlled, three-armed, parallel-group trial of transcranial magnetic stimulation for treatment-resistant depression — Front Psychiatry (PMID 42890690) | clinical-trials-landscape, neuromodulation |
| 2026-10-01 | Home Transcranial Direct Current Stimulation With Gamified Cognitive Control Training for Depression: A Randomized Clinical Trial — JAMA Netw Open (PMID 42895746) | clinical-trials-landscape, neuromodulation |
| 2026-10-01 | Transcranial alternating current stimulation for major depressive disorder: An updated systematic review and meta-analysis of randomized trials with GRADE assessment — J Affect Disord (PMID 42880603) | neuromodulation |
| 2026-09-05 | NMDA subunit 2B-selective negative allosteric modulator satoprodil (BI 1569912) as mono- and adjunctive therapy in patients with major depressive disorder: results from two phase 2 randomized, controlled trials — Neuropsychopharmacology (PMID 42701110) | ketamine-and-glutamatergic-agents |
| 2026-08-06 | Psilocybin-assisted therapy for treatment-resistant major depressive disorder in a public healthcare setting: a randomized controlled trial — Nat Med (PMID 42562964) | psychedelics-and-novel-therapeutics |
| 2026-08-04 | Resting-state fMRI-based machine learning for predicting SSRI treatment response in major depressive disorder — BMC Psychiatry (PMID 42552532) | biomarkers-and-treatment-prediction |
| 2026-08-02 | Dysregulated adult hippocampal neurogenesis in major depressive disorder — Nat Med (PMID 42629468) | neurobiology-and-mechanisms |
Migraine¶
last week: 0 · last month: 1 · last 2 months: 4 · last 3 months: 10 · last 6 months: 16 · last year: 23 · 397 cited in total · full recency page
Published in the last 3 months:
| Published | Paper | Cited on |
|---|---|---|
| 2026-10-02 | Longitudinal effects of CGRP-targeting migraine therapies on blood pressure and body mass index: A 12-month retrospective analysis — Headache (PMID 42928575) | preventive-treatment |
| 2026-10-01 | Plasma amylin levels in migraine and after erenumab treatment: A REFORM study — Headache (PMID 42867283) | biomarkers |
| 2026-09-24 | Primary care clinicians' perspectives on migraine management in Aotearoa New Zealand: a qualitative study — J Prim Health Care (PMID 41134026) | patient-experience-and-advocacy |
| 2026-09-01 | 2026 Taiwan guidelines for the acute pharmacologic treatment of migraine in adults — J Chin Med Assoc (PMID 42723131) | guidelines |
| 2026-08-04 | Effectiveness of Onabotulinumtoxin-A in Patients with Chronic Migraine and Previous CGRP-mAb Treatment Failure: A Multicentre 6-Month Real-World Experience — Toxins (Basel) (PMID 42646770) | preventive-treatment |
| 2026-08-03 | Genomic Architecture of Migraine: A Multi-ancestry GWAS Meta-analysis of 2.5 Million Participants — medRxiv (PMID 42922860) | biomarkers |
| 2026-08-03 | Pharmacologic Treatment for Migraine Prevention in Adults Practice Guideline Recommendations: Report of the AAN Guidelines Subcommittee and the American Headache Society — Headache (PMID 42673606) | guidelines |
| 2026-08-03 | Systematic Review of Pharmacologic Treatment for Migraine Prevention in Adults: Report of the AAN Guidelines Subcommittee and the American Headache Society — Headache (PMID 42673583) | guidelines |
| 2026-08-03 | Pharmacologic Treatment for Migraine Prevention in Adults Practice Guideline Recommendations: Report of the AAN Guidelines Subcommittee and the American Headache Society — Neurology (PMID 42673560) | guidelines, preventive-treatment |
| 2026-08-03 | Systematic Review of Pharmacologic Treatment for Migraine Prevention in Adults: Report of the AAN Guidelines Subcommittee and the American Headache Society — Neurology (PMID 42673559) | guidelines |
Anorexia nervosa¶
last week: 0 · last month: 2 · last 2 months: 8 · last 3 months: 9 · last 6 months: 17 · last year: 30 · 297 cited in total · full recency page
Published in the last 3 months:
| Published | Paper | Cited on |
|---|---|---|
| 2026-10-08 | Increased frequency of rare damaging variants in PLIN4 in patients with anorexia nervosa — Front Psychiatry (PMID 42923416) | genetics |
| 2026-10-02 | Patient and caregiver characteristics and outcomes following compulsory admission for anorexia nervosa treatment — BJPsych Open (PMID 42929079) | severe-enduring-illness-and-compulsory-treatment |
| 2026-10-01 | Intensive Nutritional Interventions for Anorexia Nervosa: A Commentary on Ino et al. (2026) — Int J Eat Disord (PMID 42870371) | severe-enduring-illness-and-compulsory-treatment |
| 2026-10-01 | Consensus-based clinical and research recommendations for use of glucagon-like peptide-1 receptor agonists in the context of eating disorders: a modified Delphi study — World Psychiatry (PMID 42742590) | guidelines |
| 2026-09-03 | Transcranial Direct Current Stimulation in Anorexia Nervosa: A Randomized Sham-Controlled Trial — J Clin Med (PMID 42739834) | neuromodulation-and-experimental-therapy |
| 2026-09-02 | Characteristics of Monozygotic Twins Discordant for Anorexia Nervosa: Comprehensive Risk Evaluation for Anorexia Nervosa in Twins (CREAT) Study — Eur Eat Disord Rev (PMID 42683660) | genetics |
| 2026-09-01 | Brazilian Psychiatric Association guidelines for the treatment of eating disorders — Braz J Psychiatry (PMID 42758807) | guidelines |
| 2026-09-01 | Integrative Genomic and Functional Investigation of the Multi-Layered Genetic Architecture Between Anorexia Nervosa and Bone Loss — Int J Eat Disord (PMID 42753153) | genetics |
| 2026-08-05 | An Invited Updated Systematic Review and Meta-Analysis Comparing Atypical Anorexia Nervosa and Anorexia Nervosa — Int J Eat Disord (PMID 42557659) | diagnosis-and-classification, epidemiology-and-incidence, guidelines, medical-complications, mortality-and-long-term-outcome, overview, patient-experience-and-advocacy, red-flags-and-safety-concerns |
Degenerative disc disease¶
last week: 0 · last month: 3 · last 2 months: 8 · last 3 months: 9 · last 6 months: 15 · last year: 25 · 359 cited in total · full recency page
Published in the last 3 months:
| Published | Paper | Cited on |
|---|---|---|
| 2026-10-09 | Preparation methods and clinical outcomes of platelet-rich plasma for chronic discogenic low back pain: A systematic review and meta-analysis of randomized controlled trials — PM R (PMID 42852874) | guidelines, injections-and-ablative-procedures, regenerative-and-biologic-therapy |
| 2026-10-02 | Cost-effectiveness of recommended interventions for managing low back pain: A systematic review — PLoS Med (PMID 42945153) | guidelines |
| 2026-10-02 | The ISSLS VERTEBRA initiative: establishing reporting standards for regenerative medicine trials in disc degeneration and low back pain — Eur Spine J (PMID 42900386) | regenerative-and-biologic-therapy |
| 2026-10-01 | Pain Coping Strategies Among Adult Patients with Degenerative Disc Disease — J Clin Med (PMID 42941526) | patient-experience-and-advocacy |
| 2026-09-02 | Optimal exercise dose in adults with chronic low back pain disorders: systematic review with dose-response network meta-analysis — Br J Sports Med (PMID 42785965) | conservative-treatment |
| 2026-09-02 | Assessment and Treatment of Acute Low Back Pain: A Multidisciplinary Clinical Practice Guideline — Pain Med (PMID 42687437) | guidelines |
| 2026-09-01 | Regenerative Therapies in the Management of Chronic Low Back Pain from Evidence to Practice: An Analytical Summary of the 2025 Comprehensive Evidence-Based Guidelines — Pain Physician (PMID 42804305) | guidelines |
| 2026-09-01 | Analysis of Complications Associated with Basivertebral Nerve Ablation for Vertebrogenic Low Back Pain: A Multicenter Retrospective Cohort Study of 1,145 Patients — Pain Med (PMID 42765343) | injections-and-ablative-procedures |
| 2026-08-02 | Multidisciplinary expert consensus on clinical diagnosis and therapies for low back pain — Bone Res (PMID 42660880) | guidelines, injections-and-ablative-procedures |
Asthma¶
last week: 0 · last month: 5 · last 2 months: 8 · last 3 months: 9 · last 6 months: 13 · last year: 19 · 414 cited in total · full recency page
Published in the last 3 months:
| Published | Paper | Cited on |
|---|---|---|
| 2026-10-04 | High-dose vitamin D(3) supplementation in the prevention of viral-induced asthma in high-morbidity preschoolers (DIVA): a randomised controlled trial in Canada — EClinicalMedicine (PMID 42871976) | asthma-in-children |
| 2026-10-02 | Comorbidity Burden and Clinical Management Challenges in Severe Asthma: Insights from a Pan-European SHARP Study — J Asthma Allergy (PMID 42936732) | comorbidity-and-mimics |
| 2026-10-02 | Impact of air pollution exposure in early life on lung function development in the COPSAC cohorts — BMJ Open Respir Res (PMID 42933820) | genetics-environment-and-prevention |
| 2026-10-02 | The Effect of Nasal Corticosteroids and Antihistamines on Asthma Control in Patients with Asthma and Comorbid Allergic Rhinitis: A Systematic Review — J Asthma (PMID 42904911) | comorbidity-and-mimics |
| 2026-10-02 | A self-controlled case series to evaluate the effects of clinical trial eligibility criteria on biologic-associated reductions in severe asthma exacerbations: an analysis of the CHRONICLE study — Eur Respir J (PMID 42242757) | clinical-trials-landscape |
| 2026-09-01 | Application of type 2 inflammation-related biomarkers in risk prediction models for acute exacerbations in adult asthma: a systematic review — Front Med (Lausanne) (PMID 42827866) | biomarkers |
| 2026-09-01 | Prevalence of asthma among African children and adolescents: findings from the Chronic Respiratory Disease Observatory for Africa (CHEST-Africa) — Thorax (PMID 42744587) | epidemiology-and-global-burden |
| 2026-09-01 | Accuracy of type 2 inflammatory biomarkers to diagnose asthma in adults and children: a meta-analysis of 30 studies with prospective validation in an adult primary care cohort — Lancet Respir Med (PMID 42743935) | biomarkers, diagnosis-and-objective-testing |
| 2026-08-02 | Symptom burden to characterise, predict, and prevent asthma attacks: a patient-level meta-analysis of randomised trials and translational prospective studies — Lancet Respir Med (PMID 42624803) | biomarkers |
Spinal stenosis¶
last week: 0 · last month: 0 · last 2 months: 4 · last 3 months: 5 · last 6 months: 8 · last year: 25 · 347 cited in total · full recency page
Published in the last 3 months:
| Published | Paper | Cited on |
|---|---|---|
| 2026-10-01 | Symptom duration and postoperative outcomes in degenerative cervical myelopathy: a systematic review and meta-analysis — Neurosurg Rev (PMID 42891726) | cervical-stenosis-and-myelopathy |
| 2026-10-01 | Outcome of Patients With Mild Degenerative Cervical Myelopathy Treated Nonoperatively: An Observational Study From the Canadian Spine Outcome and Research Network: Corrigendum — Neurosurgery (PMID 42875892) | cervical-stenosis-and-myelopathy |
| 2026-10-01 | Degenerative cervical myelopathy: early detection and the potential for preventing disability — Lancet Neurol (PMID 42869062) | cervical-stenosis-and-myelopathy |
| 2026-09-02 | AO Spine Clinical Practice Recommendations for Mild Degenerative Cervical Myelopathy: Contemporary Concepts — Global Spine J (PMID 42784504) | cervical-stenosis-and-myelopathy, guidelines |
| 2026-08-03 | Discrepancy Between Clinician- and Patient-Reported Definitions of Mild Degenerative Cervical Myelopathy and Surgical Outcomes — Global Spine J (PMID 42670800) | cervical-stenosis-and-myelopathy |
Retinoblastoma¶
last week: 0 · last month: 0 · last 2 months: 4 · last 3 months: 5 · last 6 months: 7 · last year: 19 · 373 cited in total · full recency page
Published in the last 3 months:
| Published | Paper | Cited on |
|---|---|---|
| 2026-10-01 | Multi-institutional study evaluating the role of liquid biopsy to determine risk of extraocular disease, therapy response and recurrence in retinoblastoma — Clin Cancer Res (PMID 42873577) | extraocular-metastatic-and-trilateral-disease, molecular-pathogenesis-and-cell-of-origin |
| 2026-10-01 | Proton Radiotherapy Decreases Incidence of Radiation-Induced Second Malignant Neoplasms Compared to Photon Radiotherapy in Patients With Retinoblastoma — Pediatr Blood Cancer (PMID 42861579) | second-cancers-and-survivorship |
| 2026-09-02 | Global retinoblastoma service availability in 2024 and equity trends since 2017 — Br J Ophthalmol (PMID 42463304) | global-access-and-outcome-disparity, systemic-chemotherapy |
| 2026-09-01 | Risk of subsequent primary melanoma in 68 002 five-year survivors of childhood and adolescent cancer in Europe: the PanCareSurFup cohort study — J Natl Cancer Inst (PMID 41915055) | second-cancers-and-survivorship |
| 2026-08-03 | Intra-arterial chemotherapy for retinoblastoma: a structured narrative review — World J Pediatr Surg (PMID 42553724) | intra-arterial-chemotherapy |
Lung squamous cell carcinoma¶
last week: 0 · last month: 1 · last 2 months: 4 · last 3 months: 5 · last 6 months: 10 · last year: 12 · 334 cited in total · full recency page
Published in the last 3 months:
| Published | Paper | Cited on |
|---|---|---|
| 2026-10-08 | FIND: a phase-II study to evaluate the efficacy and safety of erdafitinib in FGFR-altered NSCLC — Clin Cancer Res (PMID 42848441) | failed-and-frontier-targets |
| 2026-09-06 | Induction and consolidation atezolizumab with stereotactic body radiation therapy versus radiation alone in high-risk, early-stage non-small-cell lung cancer (SWOG/NRG S1914): a multicentre, open-label, superiority, phase 3, randomised controlled trial — Lancet (PMID 42702214) | clinical-trials-landscape, early-stage-and-perioperative-therapy |
| 2026-09-03 | Phase II Study of Cisplatin/Gemcitabine Plus Necitumumab for Squamous NSCLC After ICI-Platinum Therapy (WJOG14120L) — Cancer Sci (PMID 42816458) | chemotherapy-and-histology-constraints, clinical-trials-landscape |
| 2026-09-01 | High-risk human papillomavirus infection and immunohistochemical expression patterns of p16 and Rb in primary and metastatic squamous cell carcinoma of the lung — Virchows Arch (PMID 42758332) | histology-and-diagnosis |
| 2026-08-02 | Perioperative Durvalumab for Resectable Non-Small Cell Lung Cancer: Updated Outcomes From the Phase III AEGEAN Trial — J Clin Oncol (PMID 42664473) | early-stage-and-perioperative-therapy |
Uterine adenosarcoma¶
last week: 0 · last month: 1 · last 2 months: 4 · last 3 months: 4 · last 6 months: 5 · last year: 6 · 73 cited in total · full recency page
Published in the last 3 months:
| Published | Paper | Cited on |
|---|---|---|
| 2026-10-02 | Hysterectomy-corrected, age-specific incidence and survival of uterine sarcomas by histotype, race and ethnicity in the United States, 2000-2019 — Am J Obstet Gynecol (PMID 42951232) | epidemiology-and-burden, overview |
| 2026-10-01 | A SMARCA4-Deficient Uterine Sarcoma Arising in a Uterine Adenosarcoma: Expanding the Spectrum of SMARCA4-Deficient Uterine Neoplasms With Hybrid Morphologic Features — Int J Surg Pathol (PMID 42862247) | molecular-and-genomic-features |
| 2026-09-08 | Clinical Outcomes and Prognostic Factors in Uterine Adenosarcoma: A Multicenter Retrospective Cohort Study — Cancers (Basel) (PMID 42794871) | epidemiology-and-burden, overview, recurrence-and-surveillance, sarcomatous-overgrowth, staging-and-prognostic-factors, surgical-management |
| 2026-09-01 | Annual Report of the Committee on Gynecologic Oncology, the Japan Society of Obstetrics and Gynecology: Annual Patient Report for 2023 and Annual Treatment Report for 2018 — J Obstet Gynaecol Res (PMID 42706489) | epidemiology-and-burden |
Fibromyalgia¶
last week: 0 · last month: 1 · last 2 months: 2 · last 3 months: 2 · last 6 months: 9 · last year: 21 · 395 cited in total · full recency page
Published in the last 3 months:
| Published | Paper | Cited on |
|---|---|---|
| 2026-10-05 | Drug treatments for fibromyalgia: systematic review and network meta-analysis of randomised trials — BMJ Med (PMID 42851751) | pharmacologic-therapy |
| 2026-09-01 | Efficacy and safety of rozanolixizumab in severe fibromyalgia: a phase 2A randomised, double-blind, placebo-controlled, multicentre trial — Lancet Rheumatol (PMID 42748952) | autoimmunity-and-inflammation, clinical-trials-landscape |
Recency is not quality — an old paper is often the definitive one, and a new paper may not replicate. This shows movement, not merit. Each condition's own recency page adds the full age breakdown and flags which of its pages rest on the freshest evidence.